| Blessing B Nwosu, MD | |
|
740 N Macomb St, Monroe, MI 48162-7813 | |
| (734) 240-5238 | |
| (734) 240-5273 |
| Full Name | Blessing B Nwosu |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 40 Years |
| Location | 740 N Macomb St, Monroe, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750324240 | NPI | - | NPPES |
| 7215336 | Other | MI | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 4301068980 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy St Vincent Medical Center | Toledo, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southwest Ohio Anesthesia Consultants Llc | 6901700640 | 363 |
News Archive
IDEV Technologies, Incorporated, today announced the FDA has granted 510(k) clearance for the company's 6 French (6Fr) SUPERA VERITAS Transhepatic Biliary Stent System.
Before it was learned that matter burns by taking up oxygen, most chemists sought to explain combustion as the release of a mysterious substance, which they named "phlogiston". Phlogiston theory was a conceptual breakthrough that helped chemists conduct experiments and share ideas. Only when it came to pinning down the distinctive physical properties of phlogiston did it become clear that no such thing exists.
Varian, Inc. announced today the availability of its next generation dissolution apparatus designed for testing tablets, capsules and other dosage forms. The 708-DS supports a broad set of applications ranging from manual dissolution testing to automated, high-throughput analysis. It provides extensive flexibility to match the needs of individual laboratories, whether in research or testing. Integration with either the new Varian UV or LC Dissolution Systems will save time and reduce the potential for sample handling errors.
A research team from the University of British Columbia and the Child & Family Research Institute (CFRI) at BC Children's Hospital has identified the role of a type of T cell in type 1 diabetes that may lead to new treatment options for young patients.
Nicotine at doses similar to those found in most nicotine replacements therapies did not increase lung cancer tumor incidence, frequency or size, according to results of a mouse study presented at the AACR 102nd Annual Meeting 2011, held here April 2-6.
› Verified 3 days ago
| Entity Name | Southwest Ohio Anesthesia Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588645188 PECOS PAC ID: 6901700640 Enrollment ID: O20031124000399 |
News Archive
IDEV Technologies, Incorporated, today announced the FDA has granted 510(k) clearance for the company's 6 French (6Fr) SUPERA VERITAS Transhepatic Biliary Stent System.
Before it was learned that matter burns by taking up oxygen, most chemists sought to explain combustion as the release of a mysterious substance, which they named "phlogiston". Phlogiston theory was a conceptual breakthrough that helped chemists conduct experiments and share ideas. Only when it came to pinning down the distinctive physical properties of phlogiston did it become clear that no such thing exists.
Varian, Inc. announced today the availability of its next generation dissolution apparatus designed for testing tablets, capsules and other dosage forms. The 708-DS supports a broad set of applications ranging from manual dissolution testing to automated, high-throughput analysis. It provides extensive flexibility to match the needs of individual laboratories, whether in research or testing. Integration with either the new Varian UV or LC Dissolution Systems will save time and reduce the potential for sample handling errors.
A research team from the University of British Columbia and the Child & Family Research Institute (CFRI) at BC Children's Hospital has identified the role of a type of T cell in type 1 diabetes that may lead to new treatment options for young patients.
Nicotine at doses similar to those found in most nicotine replacements therapies did not increase lung cancer tumor incidence, frequency or size, according to results of a mouse study presented at the AACR 102nd Annual Meeting 2011, held here April 2-6.
› Verified 3 days ago
| Entity Name | Northstar Anesthesia Of Ohio Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417276429 PECOS PAC ID: 3173648300 Enrollment ID: O20100927000005 |
News Archive
IDEV Technologies, Incorporated, today announced the FDA has granted 510(k) clearance for the company's 6 French (6Fr) SUPERA VERITAS Transhepatic Biliary Stent System.
Before it was learned that matter burns by taking up oxygen, most chemists sought to explain combustion as the release of a mysterious substance, which they named "phlogiston". Phlogiston theory was a conceptual breakthrough that helped chemists conduct experiments and share ideas. Only when it came to pinning down the distinctive physical properties of phlogiston did it become clear that no such thing exists.
Varian, Inc. announced today the availability of its next generation dissolution apparatus designed for testing tablets, capsules and other dosage forms. The 708-DS supports a broad set of applications ranging from manual dissolution testing to automated, high-throughput analysis. It provides extensive flexibility to match the needs of individual laboratories, whether in research or testing. Integration with either the new Varian UV or LC Dissolution Systems will save time and reduce the potential for sample handling errors.
A research team from the University of British Columbia and the Child & Family Research Institute (CFRI) at BC Children's Hospital has identified the role of a type of T cell in type 1 diabetes that may lead to new treatment options for young patients.
Nicotine at doses similar to those found in most nicotine replacements therapies did not increase lung cancer tumor incidence, frequency or size, according to results of a mouse study presented at the AACR 102nd Annual Meeting 2011, held here April 2-6.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Blessing B Nwosu, MD 740 N Macomb St, Monroe, MI 48162-7813 Ph: (734) 240-5238 | Blessing B Nwosu, MD 740 N Macomb St, Monroe, MI 48162-7813 Ph: (734) 240-5238 |
News Archive
IDEV Technologies, Incorporated, today announced the FDA has granted 510(k) clearance for the company's 6 French (6Fr) SUPERA VERITAS Transhepatic Biliary Stent System.
Before it was learned that matter burns by taking up oxygen, most chemists sought to explain combustion as the release of a mysterious substance, which they named "phlogiston". Phlogiston theory was a conceptual breakthrough that helped chemists conduct experiments and share ideas. Only when it came to pinning down the distinctive physical properties of phlogiston did it become clear that no such thing exists.
Varian, Inc. announced today the availability of its next generation dissolution apparatus designed for testing tablets, capsules and other dosage forms. The 708-DS supports a broad set of applications ranging from manual dissolution testing to automated, high-throughput analysis. It provides extensive flexibility to match the needs of individual laboratories, whether in research or testing. Integration with either the new Varian UV or LC Dissolution Systems will save time and reduce the potential for sample handling errors.
A research team from the University of British Columbia and the Child & Family Research Institute (CFRI) at BC Children's Hospital has identified the role of a type of T cell in type 1 diabetes that may lead to new treatment options for young patients.
Nicotine at doses similar to those found in most nicotine replacements therapies did not increase lung cancer tumor incidence, frequency or size, according to results of a mouse study presented at the AACR 102nd Annual Meeting 2011, held here April 2-6.
› Verified 3 days ago
Lesly Pompy, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 730 N Macomb St, Suite 410, Monroe, MI 48162 Phone: 734-242-9482 Fax: 734-242-6503 | |
Jayashree Aithal, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 740 N Macomb St, Monroe, MI 48162 Phone: 734-240-5238 Fax: 734-240-5273 | |
Hany H Isak, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 740 N Macomb St, Monroe, MI 48162 Phone: 734-240-5238 Fax: 734-240-5273 | |
Dr. Richard Nivala, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 5623 E Dunbar Rd, Monroe, MI 48161 Phone: 734-241-3891 Fax: 734-241-0014 | |
Anupama A Shah, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 740 N Macomb St, Monroe, MI 48162 Phone: 734-240-5238 Fax: 734-240-5273 |